Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopsy
Research from M. Polkowski and co-researchers in the area of biopsy described
June 16th, 2009
"Background and study aims: Endoscopic-ultrasound-guided trucut needle biopsy (EUS-TCB) has not been adequately evaluated in patients with submucosal tumors (SMTs). This prospective, Uncontrolled study involving 49 consecutive patients with hypoechoic gastric SMTs (>= 20 mm) evaluated diagnostic yield and 30-day morbidity of EUS-TCB, factors related to the success of EUS-TCB, and agreement between EUS-TCB and the surgical pathology diagnosis," researchers in Warsaw, Poland report. "Seventy-three percent of tumors were gastrointestinal stromal tumors (GIST). Tumor tissue adequate for diagnosis was obtained by EUS-TCB in 31 patients (63%; 95%CI 49% to 75%). In the...
Source: Cancer Weekly (2009-06-16)
|
